What's New
| Newsletters Optimal Treatment of Myelofibrosis: Advances and Challenges Srdan Verstovsek, MD, PhD |
| Continuing Education Improving Patient Outcomes in Myelofibrosis: Writing the Next Chapter in the JAK Inhibitor Story Srdan Verstovsek, MD, PhD – Chair; Rami S. Komrokji, MD; Prithviraj Bose, MD |